Ban EM (1994) Interleukin-1 receptors in the brain: characterization by quantitative in situ autoradiography. Immunomethods 5:31–40. https://doi.org/10.1006/immu.1994.1035
Article
CAS
PubMed
Google Scholar
Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR (1995) Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 37:800–805. https://doi.org/10.1002/ana.410370614
Article
CAS
PubMed
Google Scholar
Bis JC, Heckbert SR, Smith NL, Reiner AP, Rice K, Lumley T, Hindorff LA, Marciante KD, Enquobahrie DA, Monks SA et al (2008) Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. Atherosclerosis 198:166–173. https://doi.org/10.1016/j.atherosclerosis.2007.09.031
Article
CAS
PubMed
Google Scholar
Boehme AK, McClure LA, Zhang Y, Luna JM, Del Brutto OH, Benavente OR, Elkind MS (2016) Inflammatory markers and outcomes after lacunar Stroke: levels of inflammatory markers in treatment of Stroke study. Stroke 47:659–667. https://doi.org/10.1161/STROKEAHA.115.012166
Article
CAS
PubMed
PubMed Central
Google Scholar
Bokhari FA, Shakoori TA, Butt A, Ghafoor F (2014) TNF-alpha: a risk factor for ischemic stroke. J Ayub Med Coll Abbottabad 26:111–114
PubMed
Google Scholar
Brambilla R, Ashbaugh JJ, Magliozzi R, Dellarole A, Karmally S, Szymkowski DE, Bethea JR (2011) Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination. Brain 134:2736–2754. https://doi.org/10.1093/brain/awr199
Article
PubMed
PubMed Central
Google Scholar
Brambilla R, Couch Y, Lambertsen KL (2013) The effect of stroke on immune function. Mol Cell Neurosci 53:26–33. https://doi.org/10.1016/j.mcn.2012.08.011
Article
CAS
PubMed
Google Scholar
Butt JH, Rostrup E, Hansen AS, Lambertsen KL, Kruuse C (2018) Induction of migraine-like headache, but not aura, by cilostazol in patients with migraine with aura. Brain 141:2943–2951. https://doi.org/10.1093/brain/awy228
Article
PubMed
Google Scholar
Clausen B, Degn M, Martin N, Couch Y, Karimi L, Ormhoj M, Mortensen ML, Gredal H, Gardiner C, Sargent II et al (2014) Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia. J Neuroinflammation 11:203. https://doi.org/10.1186/PREACCEPT-2982253041347736
Article
PubMed
PubMed Central
Google Scholar
Clausen BH, Degn M, Sivasaravanaparan M, Fogtmann T, Andersen MG, Trojanowsky MD, Gao H, Hvidsten S, Baun C, Deierborg T et al (2016) Conditional ablation of myeloid TNF increases lesion volume after experimental stroke in mice, possibly via altered ERK1/2 signaling. Sci Rep 6:29291. https://doi.org/10.1038/srep29291
Article
PubMed
PubMed Central
Google Scholar
Clausen BH, Lambertsen KL, Babcock AA, Holm TH, Dagnaes-Hansen F, Finsen B (2008) Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation 5:46. 1742-2094-5-46 [pii]. https://doi.org/10.1186/1742-2094-5-46
Article
CAS
PubMed
PubMed Central
Google Scholar
Clausen BH, Lambertsen KL, Dagnaes-Hansen F, Babcock AA, von Linstow CU, Meldgaard M, Kristensen BW, Deierborg T, Finsen B (2016) Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke. Acta Neuropathol. https://doi.org/10.1007/s00401-016-1541-5
Cortez-Cooper M, Meaders E, Stallings J, Haddow S, Kraj B, Sloan G, McCully KK, Cannon JG (2013) Soluble TNF and IL-6 receptors: indicators of vascular health in women without cardiovascular disease. Vasc Med 18:282–289. https://doi.org/10.1177/1358863X13508336
Article
PubMed
PubMed Central
Google Scholar
Cui G, Wang H, Li R, Zhang L, Li Z, Wang Y, Hui R, Ding H, Wang DW (2012) Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke. J Neuroinflammation 9:235. https://doi.org/10.1186/1742-2094-9-235
Article
CAS
PubMed
PubMed Central
Google Scholar
Davies CA, Loddick SA, Toulmond S, Stroemer RP, Hunt J, Rothwell NJ (1999) The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 19:87–98
Article
CAS
Google Scholar
Denes A, Ferenczi S, Kovacs KJ (2011) Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood- brain barrier damage and brain oedema independently of infarct size. J Neuroinflammation 8:164. https://doi.org/10.1186/1742-2094-8-164
Article
CAS
PubMed
PubMed Central
Google Scholar
Dziewulska D, Mossakowski MJ (2003) Cellular expression of tumor necrosis factor a and its receptors in human ischemic stroke. Clin Neuropathol 22:35–40
CAS
PubMed
Google Scholar
Emsley HC, Smith CJ, Gavin CM, Georgiou RF, Vail A, Barberan EM, Illingworth K, Scarth S, Wickramasinghe V, Hoadley ME et al (2007) Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC Neurol 7:5
Article
Google Scholar
Emsley HC, Smith CJ, Georgiou RF, Vail A, Hopkins SJ, Rothwell NJ, Tyrrell PJ, Acute Stroke I (2005) A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry 76:1366–1372. https://doi.org/10.1136/jnnp.2004.054882
Article
CAS
PubMed
PubMed Central
Google Scholar
Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, Hennerici M (1994) Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 122:135–139. https://doi.org/10.1016/0022-510x(94)90289-5
Article
CAS
PubMed
Google Scholar
Fragata I, Bustamante A, Penalba A, Ferreira P, Nunes AP, Canhao P, Montaner J (2019) Venous and arterial TNF-R1 predicts outcome and complications in acute subarachnoid hemorrhage. Neurocrit Care 31:107–115. https://doi.org/10.1007/s12028-019-00669-9
Article
CAS
PubMed
Google Scholar
Group SSS (1985) Multicenter trial of hemodilution in ischemic stroke--background and study protocol. Scandinavian Stroke Study Group. Stroke 16:885–890
Article
Google Scholar
Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC (1990) Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336–340. https://doi.org/10.1038/343336a0
Article
CAS
PubMed
Google Scholar
Hermansen SK, Christensen KG, Jensen SS, Kristensen BW (2011) Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma. J Histochem Cytochem 59:391–407. https://doi.org/10.1369/0022155411400867
Article
CAS
PubMed
PubMed Central
Google Scholar
Huang L, Wu ZB, Zhuge Q, Zheng W, Shao B, Wang B, Sun F, Jin K (2014) Glial scar formation occurs in the human brain after ischemic stroke. Int J Med Sci 11:344–348. https://doi.org/10.7150/ijms.8140
Article
PubMed
PubMed Central
Google Scholar
Intiso D, Zarrelli MM, Lagioia G, Di Rienzo F, Checchia De Ambrosio C, Simone P, Tonali P, Cioffi RP (2003) Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patinets. Neurol Sci 24:390–396
Article
Google Scholar
Kim HL, Lee JP, An JN, Kim JH, Lim WH, Seo JB, Chung WY, Oh YK, Kim YS, Lim CS et al (2017) Soluble tumor necrosis factor receptors and arterial stiffness in patients with coronary atherosclerosis. Am J Hypertens 30:313–318. https://doi.org/10.1093/ajh/hpw134
Article
CAS
PubMed
Google Scholar
Lambertsen KL, Biber K, Finsen B (2012) Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab 32:1677–1698. https://doi.org/10.1038/jcbfm.2012.88
Article
CAS
PubMed
PubMed Central
Google Scholar
Lambertsen KL, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH, Haugaard LS, Wirenfeldt M, Nielsen M, Dagnaes-Hansen F et al (2009) Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci 29:1319–1330 29/5/1319 [pii]. https://doi.org/10.1523/JNEUROSCI.5505-08.2009
Article
CAS
PubMed
PubMed Central
Google Scholar
Lambertsen KL, Clausen BH, Fenger C, Wulf H, Owens T, Dagnaes-Hansen F, Meldgaard M, Finsen B (2007) Microglia and macrophages express tumor necrosis factor receptor p75 following middle cerebral artery occlusion in mice. Neuroscience 144:934–949. https://doi.org/10.1016/j.neuroscience.2006.10.046
Article
CAS
PubMed
Google Scholar
Lambertsen KL, Finsen B, Clausen BH (2018) Post-stroke inflammation-target or tool for therapy? Acta Neuropathol. https://doi.org/10.1007/s00401-018-1930-z
Lambertsen KL, Ostergaard K, Clausen BH, Hansen S, Stenvang J, Thorsen SB, Meldgaard M, Kristensen BW, Hansen PB, Sorensen GL et al (2014) No effect of ablation of surfactant protein-D on acute cerebral infarction in mice. J Neuroinflammation 11:123. https://doi.org/10.1186/1742-2094-11-123
Article
CAS
PubMed
PubMed Central
Google Scholar
Leifer D, Kowall NW (1993) Immunohistochemical patterns of selective cellular vulnerability in human cerebral ischemia. J Neurol Sci 119:217–228
Article
CAS
Google Scholar
Licata G, Tuttolomondo A, Di Raimondo D, Corrao S, Di Sciacca R, Pinto A (2009) Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke. Thromb Haemost 101:929–937
Article
CAS
Google Scholar
Liguz-Lecznar M, Zakrzewska R, Kossut M (2015) Inhibition of Tnf-alpha R1 signaling can rescue functional cortical plasticity impaired in early post-stroke period. Neurobiol Aging 36:2877–2884. https://doi.org/10.1016/j.neurobiolaging.2015.06.015
Article
CAS
PubMed
Google Scholar
Liu X, Nemeth DP, McKim DB, Zhu L, DiSabato DJ, Berdysz O, Gorantla G, Oliver B, Witcher KG, Wang Y et al (2019) Cell-type-specific interleukin 1 receptor 1 signaling in the brain regulates distinct Neuroimmune activities. Immunity 50:764–766. https://doi.org/10.1016/j.immuni.2019.02.012
Article
CAS
PubMed
Google Scholar
Loddick SA, Rothwell NJ (1996) Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 16:932–940
Article
CAS
Google Scholar
Madsen PM, Clausen BH, Degn M, Thyssen S, Kristensen LK, Svensson M, Ditzel N, Finsen B, Deierborg T, Brambilla R et al (2016) Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with neuroprotection after focal cerebral ischemia. J Cereb Blood Flow Metab 36:1553–1569. https://doi.org/10.1177/0271678X15610339
Article
CAS
PubMed
Google Scholar
Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM et al (2006) Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam study. Circulation 113:657–663. https://doi.org/10.1161/CIRCULATIONAHA.105.555235
Article
PubMed
Google Scholar
Maysami S, Wong R, Pradillo JM, Denes A, Dhungana H, Malm T, Koistinaho J, Orset C, Rahman M, Rubio M et al (2016) A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke. J Cereb Blood Flow Metab 36:596–605. https://doi.org/10.1177/0271678X15606714
Article
CAS
PubMed
Google Scholar
Mazzotta G, Sarchielli P, Caso V, Paciaroni M, Floridi A, Floridi A, Gallai V (2004) Different cytokine levels in thrombolysis patients as predictors for clinical outcome. Eur J Neurol 11:377–381. https://doi.org/10.1111/j.1468-1331.2004.00798.x
Article
CAS
PubMed
Google Scholar
McCann SK, Cramond F, Macleod MR, Sena ES (2016) Systematic review and meta-analysis of the efficacy of Interleukin-1 receptor antagonist in animal models of Stroke: an update. Transl Stroke Res 7:395–406. https://doi.org/10.1007/s12975-016-0489-z
Article
CAS
PubMed
PubMed Central
Google Scholar
Morris CS, Esiri MM (1998) The expression of cytokines and their receptors in normal and mildly reactive human brain. J Neuroimmunol 92:85–97
Article
CAS
Google Scholar
Mulcahy NJ, Ross J, Rothwell NJ, Loddick SA (2003) Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br J Pharmacol 140:471–476
Article
CAS
Google Scholar
Nguyen TV, Frye JB, Zbesko JC, Stepanovic K, Hayes M, Urzua A, Serrano G, Beach TG, Doyle KP (2016) Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissue. Acta Neuropathol Commun 4:100. https://doi.org/10.1186/s40478-016-0371-y
Article
CAS
PubMed
PubMed Central
Google Scholar
Nielsen HH, Soares CB, Høgedahl SS, Madsen JS, Hansen RB, Christensen AA, Madsen C, Clausen BH, Frich LH, Degn M et al (2020) Acute neurofilament light chain plasma levels correlate with stroke severity and clinical outcome in ischemic stroke patients. Frontiers in Neurology In press. https://doi.org/10.3389/fneur.2020.00448
Olleros ML, Vesin D, Lambou AF, Janssens JP, Ryffel B, Rose S, Fremond C, Quesniaux VF, Szymkowski DE, Garcia I (2009) Dominant-negative tumor necrosis factor protects from Mycobacterium bovis Bacillus Calmette Guerin (BCG) and endotoxin-induced liver injury without compromising host immunity to BCG and Mycobacterium tuberculosis. J Infect Dis 199:1053–1063. https://doi.org/10.1086/597204 [pii]
Article
CAS
PubMed
Google Scholar
Ormstad H, Aass HC, Lund-Sorensen N, Amthor KF, Sandvik L (2011) Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. J Neurol 258:677–685. https://doi.org/10.1007/s00415-011-6006-0
Article
CAS
PubMed
PubMed Central
Google Scholar
Pinteaux E, Rothwell NJ, Boutin H (2006) Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia. Glia 53:551–556. https://doi.org/10.1002/glia.20308
Article
PubMed
Google Scholar
Ralph SJ, Weissenberger A, Bonev V, King LD, Bonham MD, Ferguson S, Smith AD, Goodman-Jones AA, Espinet AJ (2020) Phase I/II parallel double-blind randomized controlled clinical trial of perispinal etanercept for chronic stroke: improved mobility and pain alleviation. Expert Opin Investig Drugs 29:311–326. https://doi.org/10.1080/13543784.2020.1709822
Article
CAS
PubMed
Google Scholar
Sairanen T, Carpen O, Karjalainen-Lindsberg ML, Paetau A, Turpeinen U, Kaste M, Lindsberg PJ (2001) Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke. Stroke 32:1750–1758
Article
CAS
Google Scholar
Sairanen TR, Lindsberg PJ, Brenner M, Carpen O, Siren A (2001) Differential cellular expression of tumor necrosis factor-alpha and type I tumor necrosis factor receptor after transient global forebrain ischemia. J Neurol Sci 186:87–99
Article
CAS
Google Scholar
Scheinfeld N (2004) A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab. J Dermatolog Treat 15:280–294. https://doi.org/10.1080/09546630410017275 A6NLET3WGCNW1D14 [pii]
Article
CAS
PubMed
Google Scholar
Smith CJ, Hulme S, Vail A, Heal C, Parry-Jones AR, Scarth S, Hopkins K, Hoadley M, Allan SM, Rothwell NJ et al (2018) SCIL-STROKE (subcutaneous Interleukin-1 receptor antagonist in ischemic Stroke): a randomized controlled phase 2 trial. Stroke 49:1210–1216. https://doi.org/10.1161/STROKEAHA.118.020750
Article
CAS
PubMed
Google Scholar
Sotgiu S, Zanda B, Marchetti B, Fois ML, Arru G, Pes GM, Salaris FS, Arru A, Pirisi A, Rosati G (2006) Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol 13:505–513
Article
CAS
Google Scholar
Sumbria RK, Boado RJ, Pardridge WM (2012) Brain protection from stroke with intravenous TNFalpha decoy receptor-Trojan horse fusion protein. J Cereb Blood Flow Metab 32:1933–1938. https://doi.org/10.1038/jcbfm.2012.97
Article
CAS
PubMed
PubMed Central
Google Scholar
Svensson EH, Soderholm M, Abul-Kasim K, Engstrom G (2017) Tumor necrosis factor receptor 1 and 2 are associated with risk of Intracerebral hemorrhage. Stroke 48:2710–2715. https://doi.org/10.1161/STROKEAHA.117.017849
Article
CAS
PubMed
Google Scholar
Taoufik E, Tseveleki V, Chu SY, Tselios T, Karin M, Lassmann H, Szymkowski DE, Probert L (2011) Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB. Brain 134:2722–2735. https://doi.org/10.1093/brain/awr203
Article
PubMed
Google Scholar
Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, Tarkowski A (1995) Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26:1393–1398
Article
CAS
Google Scholar
Tobinick E, Kim NM, Reyzin G, Rodriguez-Romanacce H, DePuy V (2012) Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS drugs 26:1051–1070. https://doi.org/10.1007/s40263-012-0013-2
Article
CAS
PubMed
Google Scholar
Tomimoto H, Akiguchi I, Wakita H, Kinoshita A, Ikemoto A, Nakamura S, Kimura J (1996) Glial expression of cytokines in the brains of cerebrovascular disease patients. Acta Neuropathol (Berl) 92:281–287
Article
CAS
Google Scholar
Tuttolomondo A, Di Sciacca R, Di Raimondo D, Serio A, D'Aguanno G, La Placa S, Pecoraro R, Arnao V, Marino L, Monaco S et al (2009) Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site. J Neuroimmunol 215:84–89. https://doi.org/10.1016/j.jneuroim.2009.06.019
Article
CAS
PubMed
Google Scholar
Um JY, An NH, Kim HM (2003) TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction. J Mol Neurosci 21:167–171
Article
CAS
Google Scholar
Um JY, Moon KS, Lee KM, Yun JM, Cho KH, Moon BS, Kim HM (2003) Association of interleukin-1 alpha gene polymorphism with cerebral infarction. Brain Res Mol Brain Res 115:50–54
Article
CAS
Google Scholar
van Sloten TT, Sedaghat S, Laurent S, London GM, Pannier B, Ikram MA, Kavousi M, Mattace-Raso F, Franco OH, Boutouyrie P et al (2015) Carotid stiffness is associated with incident stroke: a systematic review and individual participant data meta-analysis. J Am Coll Cardiol 66:2116–2125. https://doi.org/10.1016/j.jacc.2015.08.888
Article
PubMed
Google Scholar
Vila N, Castillo J, Davalos A, Chamorro A (2000) Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31:2325–2329
Article
CAS
Google Scholar
Vila N, Filella X, Deulofeu R, Ascaso C, Abellana R, Chamorro A (1999) Cytokine-induced inflammation and long-term stroke functional outcome. J Neurol Sci 162:185–188. https://doi.org/10.1016/s0022-510x(98)00319-0
Article
CAS
PubMed
Google Scholar
Wang X, Li X, Currie RW, Willette RN, Barone FC, Feuerstein GZ (2000) Application of real-time polymerase chain reaction to quantitate induced expression of interleukin-1beta mRNA in ischemic brain tolerance. J Neurosci Res 59:238–246
Article
CAS
Google Scholar
Wytrykowska A, Prosba-Mackiewicz M, Nyka WM (2016) IL-1beta, TNF-alpha, and IL-6 levels in gingival fluid and serum of patients with ischemic stroke. J Oral Sci 58:509–513. https://doi.org/10.2334/josnusd.16-0278
Article
CAS
PubMed
Google Scholar
Yli-Karjanmaa M, Clausen BH, Degn M, Novrup HG, Ellman DG, Toft-Jensen P, Szymkowski DE, Stensballe A, Meyer M, Brambilla R et al (2019) Topical administration of a soluble TNF inhibitor reduces infarct volume after focal cerebral ischemia in mice. Front Neurosci 13:781
Article
Google Scholar
Zaremba J, Losy J (2001) Early TNF-alpha levels correlate with ischaemic stroke severity. Acta Neurol Scand 104:288–295
Article
CAS
Google Scholar
Zeng L, Wang Y, Liu J, Wang L, Weng S, Chen K, Domino EF, Yang GY (2013) Pro-inflammatory cytokine network in peripheral inflammation response to cerebral ischemia. Neurosci Lett 548:4–9. https://doi.org/10.1016/j.neulet.2013.04.037
Article
CAS
PubMed
Google Scholar